The European Congress on Advanced Clinical Trials and Clinical Research, taking place on August 11–12, 2027, in London, UK, is a premier international platform dedicated to advancing clinical research, clinical trial methodology, therapeutic development, evidence generation, regulatory science, and patient-centered research. The congress will bring together clinical researchers, physicians, principal investigators, clinical trial professionals, biostatisticians, epidemiologists, regulatory experts, pharmaceutical and biotechnology professionals, medical device specialists, research organizations, academicians, data scientists, healthcare professionals, and technology innovators to exchange knowledge, present research, discuss methodological advances, and explore emerging developments in clinical research.
Under the theme “Advancing Clinical Research: Innovative Trial Design, Evidence Generation & Better Patient Outcomes,” the congress will explore the rapidly evolving landscape of clinical trials and research, focusing on innovative trial methodologies, adaptive and pragmatic trial designs, decentralized clinical trials, real-world evidence, precision medicine, digital technologies, advanced analytics, patient engagement, regulatory innovation, and efficient evidence generation. The scientific program will address key areas including early-phase and late-phase clinical trials, clinical trial design, protocol development, statistical methodology, patient recruitment, clinical data management, safety monitoring, clinical endpoints, biomarkers, medical devices, digital therapeutics, translational research, and evidence-based healthcare. A major focus will be placed on innovative clinical trial design and methodology, exploring adaptive trials, platform trials, basket trials, umbrella trials, master protocols, pragmatic clinical trials, crossover designs, randomized controlled trials, single-arm studies, observational research, and innovative approaches to clinical development. Discussions will address protocol optimization, endpoint selection, comparator strategies, sample-size determination, interim analysis, statistical efficiency, trial feasibility, patient recruitment, retention, and strategies for improving the quality, speed, and reliability of clinical research.